Painful Neuropathy Program
Screen. Test. Treat.
Turnkey Neuropathy Program
Painful Neuropathy Program
Establishing a comprehensive Painful Neuropathy Program is a turnkey solution that significantly elevates patient care through advanced diagnostics and targeted interventions.
The Diabetic Neuropathy Device™ provides thoroughly assesses both small and large fiber functions, allowing precise identification and measurement of neuropathy types. This invaluable data empowers healthcare providers to tailor interventions effectively. Furthermore, the inclusion of NutriNerve® supplements, formulated by the internationally renowned endocrinologist and leading expert on diabetic neuropathy, Dr. Aaron Vinik, MD PhD, and supports the maintenance of a healthy nervous system. Recognized as the #1 Supplement that Scientific Thinking can Offer for Nerve Health, these all-natural supplements aid cellular repair. The program, combining state-of-the-art diagnostics and natural supplements, ensures a holistic approach to managing and mitigating diabetic neuropathy, ultimately enhancing patients' quality of life.
Screen.
A monofilament screening is a subjective test that evaluates sensory perception in the feet, especially in those with diabetes.
Test.
Our objective device identifies, measures, and verifies both small-fiber and large-fiber neuropathy.
Treat.
'Best supplement that scientific thinking can offer for nerves,' by renowned Endocrinologist A. Vinik MD PhD.
"Every medical practice should test patients with the DND before referring them to a specialist because it can help identify potential underlying conditions that may require further investigation or treatments." -J. Gonzalez MD, Neurologist
Screening.
Medical providers often rely on outdated subjective tools for screening diabetic neuropathy, like the tuning fork (inv. 1711 and the monofilament (inv. 1938), which can lead to missed opportunities for early intervention. Traditional methods, such as patient self-reporting and monofilament testing, lack the precision and sensitivity for early detection. These subjective tools may result in false-positive or false-negative results, contributing to inaccurate assessments of neuropathy risk. False positives can trigger unnecessary anxiety and interventions, while false negatives may lead to delayed diagnosis and intervention, missing crucial opportunities to address neuropathy in its early stages.
Diabetic Neuropathy Accounts for More Hospitalizations Than All Other Diabetic Complications Combined...
Aaron Vinik, MD, Ph.D., Endocrinologist, Diabetic Neuropathies, February 5, 2018
The consequences of relying on outdated tools are profound. Early intervention in diabetic neuropathy is pivotal for preventing or mitigating complications, such as foot ulcers and amputations. Subjective tools often fail to capture subtle changes in nerve function, contributing to delayed or overlooked diagnoses. Integrating advanced diagnostics, such as the Diabetic Neuropathy Device™, into routine screenings can overcome these limitations. This state-of-the-art device offers objective assessments of both small and large fiber functions, providing accurate and timely information for medical providers. By embracing modern diagnostic approaches, healthcare professionals can enhance their ability to detect diabetic neuropathy early, improving patient outcomes and reducing the overall burden of neuropathic complications.
"One of the great advantages of using the DND on our diabetic patients who have started to develop diabetic neuropathy, is that showing them their results, often makes the consequences of not taking care of themselves more realistic." -S. Erle DC, Neuropathy Centers
Testing.
Testing for neuropathy and utilizing modern technology, such as the Diabetic Neuropathy Device™ (DND) is paramount in meeting the evolving guidelines set by the American Diabetes Association (ADA) for diabetes screening and diagnosis. It is expected, if not an obligation, for medical providers to utilize the most modern and objective diagnostic tools in medicine rather than relying on subjective tools such as tuning forks (invented in 1711) and monofilaments (invented in 1938). The DND stands out as the sole tool capable of screening distal symmetric polyneuropathy (DSPN), aligning with the ADA's recommendations for assessing both small fiber function (temperature) and large fiber function (vibration). These advanced capabilities make the DND essential in adhering to the new standards outlined in the Diabetic Neuropathy: A Position Statement by the American Diabetes Association. The precise assessments provided by the DND empower healthcare providers with accurate information, ensuring a comprehensive evaluation aligned with the latest guidelines.
The Device (DND) Replaces Tuning Forks and Monofilaments...
Kazu Suzuki DPM, Medical Director of the Tower Wound Care Center at the Cedars-Sinai Medical Towers in Los Angeles, CA; Managing Neuropathy And Pain In Wound Care Patients, Podiatry Today; September 2015; 26-27.
Tailoring neuropathy treatments to address each patient's unique clinical presentation and underlying pathogenesis is crucial, especially in avoiding the adverse effects associated with opioids. For instance, administering pain relief medication to patients with painful neuropathy might alleviate symptoms but could mask the loss of protective sensation (LOPS) in their feet. This masking effect increases the risk of foot ulcers and amputation. Identifying individuals in the early stages of the neuropathic process is, therefore, vital, enabling more effective risk reduction strategies and personalized treatment plans that address the root causes of neuropathy. The DND is pivotal in this approach, offering a sophisticated tool for accurate assessments and early intervention.
Two Major Modalities in One Simple-to-Use Handheld Device
Boris Golosarsky, MD MACP FACPI, Podiatry Management, Profiles in Excellence, January 2015
After 2 months of taking NutriNerve® I have seen about a 40% improvement in all my Neuropathy symptoms. - Robert Sherman MD
Treating.
NutriNerve® is a crucial therapeutic option for individuals experiencing both painful neuropathy (small-fiber conditions) and painless neuropathy (large-fiber conditions). Dr. Aaron Vinik, MD PhD, a leading expert in diabetic neuropathy, developed NutriNerve® supplements with meticulous formulation to combat nutritional deficiencies associated with neuropathy. By targeting these deficiencies, NutriNerve® supports cellular repair on a profound level, promoting the overall health of the nervous system. This dual-action approach makes it a versatile and comprehensive solution for individuals experiencing various neuropathic symptoms, ranging from pain and discomfort to sensory deficits.
#1 Supplement that Scientific Thinking Can Offer
for Nerve Health
One of the standout features of NutriNerve® is its affordability, making it an accessible long-term maintenance option when prescribed by a medical provider. The cost-effectiveness of NutriNerve® ensures that patients can sustain their neuropathy management plan without compromising on the quality of care. This affordability factor enhances patient compliance and encourages consistent use, aligning to promote ongoing nerve health. As a result, NutriNerve® not only addresses the immediate symptoms of neuropathy and provides a sustainable and economically viable approach to long-term maintenance, contributing to the overall well-being of individuals with diabetic neuropathy.
